The Potential of Pan-PPAR Agonist Therapy to Address Inflammation and Fibrosis in Patients with MASH – a Path to a Holistic Approach
Time: 11:15 am
day: Conference Day 2 Track 2 AM
Details:
- Delving into the anti-fibrotic and anti-inflammatory impacts
- Assessing developments from Phase 3 trials
